MicroRNA-320a sensitizes tamoxifen-resistant breast cancer cells to tamoxifen by targeting ARPP-19 and ERRÎ³.

Lü, Mingrong; Ding, Keshuo; Zhang, Guofeng; Yin, Mianmian; Yao, Guidong; Tian, Hui; Lian, Jie; Liu, Lin; Liang, Meng; Zhu, Tao; Sun, Fei

Lü, Mingrong; Ding, Keshuo; Zhang, Guofeng; Yin, Mianmian; Yao, Guidong; Tian, Hui; Lian, Jie; Liu, Lin; Liang, Meng; Zhu, Tao; Sun, Fei.

Afiliação

Lü M; 1] Institute of Immunology and CAS Key Laboratory of Innate Immunity and Chronic Disease, Innovation Center for Cell Biology, School of Life Sciences and Medical Center, University of Science and Technology of China, Hefei, Anhui 230027, People's Republic of China [2] Hefei National Laboratory for P
Ding K; 1] Institute of Immunology and CAS Key Laboratory of Innate Immunity and Chronic Disease, Innovation Center for Cell Biology, School of Life Sciences and Medical Center, University of Science and Technology of China, Hefei, Anhui 230027, People's Republic of China [2] Hefei National Laboratory for P
Zhang G; Department of General Surgery, Tongji Hospital, School of Medicine, Tongji University, Shanghai 200065, People's Republic of China.
Yin M; 1] Institute of Immunology and CAS Key Laboratory of Innate Immunity and Chronic Disease, Innovation Center for Cell Biology, School of Life Sciences and Medical Center, University of Science and Technology of China, Hefei, Anhui 230027, People's Republic of China [2] Hefei National Laboratory for P
Yao G; Reproductive Medical Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan 450052, People's Republic of China.
Tian H; 1] Institute of Immunology and CAS Key Laboratory of Innate Immunity and Chronic Disease, Innovation Center for Cell Biology, School of Life Sciences and Medical Center, University of Science and Technology of China, Hefei, Anhui 230027, People's Republic of China [2] Hefei National Laboratory for P
Lian J; 1] Institute of Immunology and CAS Key Laboratory of Innate Immunity and Chronic Disease, Innovation Center for Cell Biology, School of Life Sciences and Medical Center, University of Science and Technology of China, Hefei, Anhui 230027, People's Republic of China [2] Hefei National Laboratory for P
Liu L; 1] Institute of Immunology and CAS Key Laboratory of Innate Immunity and Chronic Disease, Innovation Center for Cell Biology, School of Life Sciences and Medical Center, University of Science and Technology of China, Hefei, Anhui 230027, People's Republic of China [2] Hefei National Laboratory for P
Liang M; 1] Institute of Immunology and CAS Key Laboratory of Innate Immunity and Chronic Disease, Innovation Center for Cell Biology, School of Life Sciences and Medical Center, University of Science and Technology of China, Hefei, Anhui 230027, People's Republic of China [2] Hefei National Laboratory for P
Zhu T; 1] Institute of Immunology and CAS Key Laboratory of Innate Immunity and Chronic Disease, Innovation Center for Cell Biology, School of Life Sciences and Medical Center, University of Science and Technology of China, Hefei, Anhui 230027, People's Republic of China [2] Hefei National Laboratory for P
Sun F; 1] Institute of Immunology and CAS Key Laboratory of Innate Immunity and Chronic Disease, Innovation Center for Cell Biology, School of Life Sciences and Medical Center, University of Science and Technology of China, Hefei, Anhui 230027, People's Republic of China [2] Hefei National Laboratory for P

Sci Rep ; 5: 8735, 2015 Mar 04.

Article em En | MEDLINE | ID: mdl-25736597

Assuntos

Neoplasias da Mama/tratamento farmacológico; Resistencia a Medicamentos Antineoplásicos/genética; MicroRNAs/genética; Fosfoproteínas/genética; Receptores de Estrogênio/genética; Tamoxifeno/farmacologia; Animais; Antineoplásicos Hormonais/farmacologia; Neoplasias da Mama/genética; Neoplasias da Mama/metabolismo; Linhagem Celular Tumoral; Sobrevivência Celular/efeitos dos fármacos; Sobrevivência Celular/genética; Estrogênios/farmacologia; Feminino; Regulação Neoplásica da Expressão Gênica/efeitos dos fármacos; Técnicas de Silenciamento de Genes; Humanos; Células MCF-7; Camundongos Nus; Fosfoproteínas/metabolismo; Progesterona/farmacologia; Proteínas Proto-Oncogênicas c-myc/genética; Proteínas Proto-Oncogênicas c-myc/metabolismo; Receptores de Estrogênio/metabolismo; Reação em Cadeia da Polimerase Via Transcriptase Reversa; Ensaios Antitumorais Modelo de Xenoenxerto/métodos

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Fosfoproteínas / Tamoxifeno / Neoplasias da Mama / Receptores de Estrogênio / Resistencia a Medicamentos Antineoplásicos / MicroRNAs Limite: Animals / Female / Humans Idioma: En Ano de publicação: 2015 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google